Get started
Author

Ritu Goila-Gaur

Observed names: Goila-Gaur, Ritu, R. Goila-Gaur, Ritu Goila-gaur
OpenAlex ID: A5048939812
PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing
2003 · F. Li, R. Goila-Gaur, et al. · Proceedings of the National Academy of Sciences · 418
HIV-1 Vif, APOBEC, and Intrinsic Immunity
2008 · Ritu Goila-Gaur, Klaus Strebel · Retrovirology · 341
PDF
Viral RNA Is Required for the Association of APOBEC3G with Human Immunodeficiency Virus Type 1 Nucleoprotein Complexes
2005 · Mohammad A. Khan, Sandra Kao, et al. · Journal of Virology · 178
PDF
Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1
2007 · Eri Miyagi, Sandrine Opi, et al. · Journal of Virology · 150
In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)
2006 · Catherine S. Adamson, Sherimay D. Ablan, et al. · Journal of Virology · 119
Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G Variant
2007 · Sandrine Opi, Sandra Kao, et al. · Journal of Virology · 99
Defects in Human Immunodeficiency Virus Budding and Endosomal Sorting Induced by TSG101 Overexpression
2003 · Ritu Goila-Gaur, Dimiter G. Demirov, et al. · Journal of Virology · 99
Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells
2004 · Sandra Kao, Eri Miyagi, et al. · Retrovirology · 94
PDF
Monomeric APOBEC3G Is Catalytically Active and Has Antiviral Activity
2006 · Sandrine Opi, Hiroaki Takeuchi, et al. · Journal of Virology · 85
Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions
2007 · Mohammad A Khan, Ritu Goila-Gaur, et al. · Retrovirology · 84
PDF
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity
2007 · Ritu Goila-Gaur, Mohammad A Khan, et al. · Retrovirology · 73
PDF
Stably Expressed APOBEC3F Has Negligible Antiviral Activity
2010 · Eri Miyagi, Charles R. Brown, et al. · Journal of Virology · 49
HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes
2007 · Ritu Goila-Gaur, Mohammad A. Khan, et al. · Virology · 49
PDF
Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif
2007 · Sandra Kao, Ritu Goila-Gaur, et al. · Virology · 43
PDF
Identification of Dominant Negative Human Immunodeficiency Virus Type 1 Vif Mutants That Interfere with the Functional Inactivation of APOBEC3G by Virus-Encoded Vif
2010 · Robert C. Walker, Mohammad A. Khan, et al. · Journal of Virology · 34
Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization
2009 · Mohammad A Khan, Ritu Goila-Gaur, et al. · Retrovirology · 31
PDF
Differential Sensitivity of “Old” versus “New” APOBEC3G to Human Immunodeficiency Virus Type 1 Vif
2008 · Ritu Goila-Gaur, Mohammad A. Khan, et al. · Journal of Virology · 17
PDF
Vif Counteracts a Cyclophilin A-Imposed Inhibition of Simian Immunodeficiency Viruses in Human Cells
2007 · Hiroaki Takeuchi, Alicia Buckler-White, et al. · Journal of Virology · 17
Works count: 41
Citation count: 1,980
H-index: 17
I10-index: 18
Year
Topic
Type